Ebola

Rockefeller Foundation President, Rajiv J. Shah, to Present at the AAGL Global Congress on Minimally Invasive Gynecologic Surgery

Retrieved on: 
Wednesday, November 23, 2022

CYPRESS, Calif., Nov. 23, 2022 /PRNewswire-PRWeb/ -- AAGL Global Congress will welcome physicians from all over the world online and live at the Gaylord Rockies Convention Center in Aurora, Colorado, USA, December 1-4, 2022. Participants will enjoy a robust, four-day, scientific program, thoughtfully developed by Dr. Andrew I. Sokol and the Scientific Program Committee. The theme of this year's Global Congress, "Dissemination of MIGS Care: Improving Access for All" captures AAGL's global vision to combine the wealth of experience of the association's worldwide physician membership and best identify ways to improve access to quality MIGS care for all women, including those in underserved populations.

Key Points: 
  • Dr. Rajiv J. Shah, President of the Rockefeller Foundation and former Administrator of USAID under President Obama, will present a Keynote Address at the American Association of Gynecologic Laparoscopists (AAGL) 51st Global Congress on Minimally Invasive Gynecologic Surgery (MIGS) on December 3, 2022.
  • AAGL's Global Congress, the premier scientific conference for gynecologic surgeons from around the world, offers high-quality education and cutting-edge best practices in MIGS.
  • The AAGL Global Congress on MIGS is the premier academic event of the year for personal and professional development in Minimally Invasive Gynecologic Surgery.
  • 2022 AAGL Global Congress Highlight Video: https://youtu.be/tnfv5I1LLLg
    AAGL is an international professional medical association of laparoscopic surgeons and the global leader in minimally invasive gynecologic surgery.

HEALTH RESEARCH FOUNDATION ANNOUNCES RECIPIENT OF ITS MEDAL OF HONOUR

Retrieved on: 
Wednesday, November 16, 2022

OTTAWA, ON, Nov. 15, 2022 /CNW/ - The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that Dr. Allison McGeer is the recipient of its distinguished Medal of Honour.

Key Points: 
  • OTTAWA, ON, Nov. 15, 2022 /CNW/ - The Health Research Foundation (HRF) of Innovative Medicines Canada is pleased to announce that Dr. Allison McGeer is the recipient of its distinguished Medal of Honour.
  • "The Health Research Foundation is extremely proud to present Dr. McGeer with its Medal of Honour.
  • "The HRF has been a longstanding pillar in the health research community and it's an honour to receive this recognition."
  • The Health Research Foundation (HRF) of Innovative Medicines Canada is a non-profit organization that invests in Canadian academic health research and promotes the value of research-driven health innovation in Canada.

Healthcare and Medical Leaders Gather to Shape the Future of Global Health

Retrieved on: 
Friday, November 11, 2022

Dr Peter K N Lam, Chairman of the HKTDC, said, "The importance of the medical and healthcare sector to the global economy cannot be overstated, especially during the past three years.

Key Points: 
  • Dr Peter K N Lam, Chairman of the HKTDC, said, "The importance of the medical and healthcare sector to the global economy cannot be overstated, especially during the past three years.
  • As markets across the world gradually recover from the fallout of the pandemic, the health crisis needs to be tackled in tandem.
  • The Summit featured more than 80 speakers, including healthcare officials and members from international organisations, scientists and medical experts, investors, business leaders, financial specialists and service providers.
  • The Medical Fair is co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA).

Ebola Outbreak Still A Risk As Designated Hospitals Can’t Treat Deadly Waste On-Site

Retrieved on: 
Monday, November 7, 2022

U.S. hospitals have been instructed to ramp up their preparedness plans, but many hospitals still arent able to sterilize the deadly Ebola waste on site.

Key Points: 
  • U.S. hospitals have been instructed to ramp up their preparedness plans, but many hospitals still arent able to sterilize the deadly Ebola waste on site.
  • However, 5 of the 13 special pathogen centers can NOT treat such waste on-site.
  • One of the greatest challenge hospitals faced during the last outbreak was handling Ebola waste, which became a prominent issue during the Ebola crisis that came under scrutiny by the press and Congress.
  • Ebola waste is classified as Category A by the US Department of Transportation (USDOT).

AIM ImmunoTech Receives Orphan Drug Designation for Ampligen (rintatolimod) for the Treatment of Ebola Virus Disease

Retrieved on: 
Wednesday, November 2, 2022

OCALA, Fla., Nov. 02, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Ampligen® (rintatolimod) for the treatment of Ebola virus disease.

Key Points: 
  • Ampligen is AIMs dsRNA product candidate being developed for globally important cancers, viral diseases and disorders of the immune system.
  • Receiving Orphan Drug Designation for Ampligen for the treatment of Ebola from the FDA is a testament to the depth and breadth of the potential with Ampligen.
  • We continue to be encouraged by the promising results Ampligen has demonstrated to date across a number of indications where there remains significant unmet need.
  • Ebola virus disease (EVD) is a rare but severe, deadly disease causing a multitude of symptoms including fever, gastrointestinal issues, aches, and bruising.1 Previous animal studies yielded positive results utilizing Ampligen in Western Equine Encephalitis Virus, Ebola, Vaccinia Virus (which is used in the manufacture of smallpox vaccine) and SARS-CoV-1.

Vaxcyte Expands Executive Leadership Team with Key Appointments

Retrieved on: 
Tuesday, October 11, 2022

SAN CARLOS, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced the appointment of Mark Wiggins as Chief Business Officer and Jakub Simon as Chief Medical Officer. Both Mark and Jakub are accomplished industry leaders who bring vast expertise that will support the continued growth and advancement of the Company.

Key Points: 
  • Vaxcyte is poised for substantial growth with a potential global PCV vaccine franchise, said Mark Wiggins, Chief Business Officer of Vaxcyte.
  • Im thrilled to be joining the Company at this stage and to be part of a dedicated, forward-thinking team on a mission to advance such important vaccines.
  • I am pleased to join this team driven by a bold mission grounded in addressing significant public health challenges with respect to bacterial infectious diseases and antibiotic resistance, said Jakub Simon, Chief Medical Officer of Vaxcyte.
  • Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.

The Rockefeller Foundation Names Natalye Paquin as New Chief Operating Officer

Retrieved on: 
Friday, September 9, 2022

NEW YORK, Sept. 9, 2022 /PRNewswire/ -- The Rockefeller Foundation announced that Natalye Paquin has been named Chief Operating Officer (COO), overseeing the global organization's Employee Services, Human Resources, Information Technology, Innovation, Finance, and Legal teams as well as its workforce at offices in the United States, Italy, Asia, and Africa. Ms. Paquin, who will begin in the role on December 1, joins the Foundation after serving as President and Chief Executive Officer of Points of Light, founded by former President George H.W. Bush to encourage people to change their communities and the wider world. She succeeds Steven VanRoekel, who is leaving the Foundation after five years.

Key Points: 
  • Ms. Paquin, who will begin in the role on December 1, joins the Foundation after serving as President and Chief Executive Officer of Points of Light, founded by former President George H.W.
  • Time and again, Natalye has strategically led mission-driven organizations, most recently Points of Light, through critical times of transformation while advancing their missions," said Dr. Rajiv J. Shah, President of The Rockefeller Foundation.
  • Ms. Paquin succeeds Steven VanRoekel, who joined the Foundation in September 2018 as interim COO before becoming permanent in March 2019.
  • "It has been one of the greatest honors and privileges of my life to work side-by-side with my Rockefeller Foundation family," said Mr. VanRoekel.

Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID

Retrieved on: 
Monday, August 15, 2022

There is an urgency for alternative solutions to provide protection against Long COVID.

Key Points: 
  • There is an urgency for alternative solutions to provide protection against Long COVID.
  • Tollovid has a 5-day dosing regimen, with 4 doses of 3 pills taken each day that provides maximum immune support.
  • Preliminary data from an ongoing IRB-waived study of customers who used the products to assist with their COVID and Long COVID were recently announced.
  • Tollovir will be developed for the treatment of hospitalized COVID-19 (severe and critical), moderate COVID-19, Long COVID and, potentially, pediatric COVID-19.

Catalytic Investment to Improve Community Health Care for Millions Across Africa

Retrieved on: 
Monday, August 8, 2022

GENEVA, Aug. 8, 2022 /PRNewswire/ -- Today the Global Fund to Fight AIDS, TB and Malaria is announcing a crucial new catalytic fund to support community health workers across up to 10 African countries. The Africa Frontline First Catalytic Fund (AFF-CF) will provide financing to accelerate and sustain the scale up of frontline community health workers, the backbone of community health services.

Key Points: 
  • Investing in frontline community health workers can generate a return of up to 10:1 when considering the improved economic, health, and social outcomes of community health workers.
  • The Africa Frontline First Catalytic Fund (AFF-CF) will provide financing to accelerate and sustain the scale up of frontline community health workers, the backbone of community health services.
  • This catalytic investment is a first step towards a broader shared ambition to scale community health, contributing to expanding universal health coverage.
  • Africa Frontline Firstis a collaborative effort by the Financing Alliance for Health, Last Mile Health, the Community Health Acceleration Partnership, and Community Health Impact Coalition under the championship of President Ellen Johnson Sirleaf.

Catalytic Investment to Improve Community Health Care for Millions Across Africa

Retrieved on: 
Monday, August 8, 2022

GENEVA, Aug. 8, 2022 /PRNewswire/ -- Today the Global Fund to Fight AIDS, TB and Malaria is announcing a crucial new catalytic fund to support community health workers across up to 10 African countries. The Africa Frontline First Catalytic Fund (AFF-CF) will provide financing to accelerate and sustain the scale up of frontline community health workers, the backbone of community health services.

Key Points: 
  • Investing in frontline community health workers can generate a return of up to 10:1 when considering the improved economic, health, and social outcomes of community health workers.
  • The Africa Frontline First Catalytic Fund (AFF-CF) will provide financing to accelerate and sustain the scale up of frontline community health workers, the backbone of community health services.
  • This catalytic investment is a first step towards a broader shared ambition to scale community health, contributing to expanding universal health coverage.
  • Africa Frontline Firstis a collaborative effort by the Financing Alliance for Health, Last Mile Health, the Community Health Acceleration Partnership, and Community Health Impact Coalition under the championship of President Ellen Johnson Sirleaf.